- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02766946
Diaphragmatic Atrophy Related to Mechanical Ventilation (ECHODIAPH)
Ultrasound Observation of Diaphragmatic Atrophy Related to Mechanical Ventilation A Prospective Monocentric Study in Intensive Care Unit
Ventilatory support during critical phase result in inactivity of respiratory muscles especially diaphragm muscle. These inactivity also result in change of contractile capability and quick muscular atrophy.
The aim of the study is to visualize the evolution of diaphragm thickness by echography during Mechanical Ventilation for patients with septic shock or acute respiratory distress syndrome and to compare with the evolution for patients under non-invasive ventilation and those with spontaneous ventilation. Measurements will be performed at day 1, day 5 and day 10 (if patient still under a mode of ventilation or in the unit).
The evolution of diaphragm thickness will also be compared to pectoralis muscle atrophy, which is not involved in ventilation, in order to assess respective effect of ventilatory inactivity and undernutrition linked to intensive care.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age ≥18 years old
- Group 1 : under Mechanical Ventilation (time of Mechanical Ventilation for at least 5 days)
- Group 2 : under Non-invasive Ventilation
- Group 3 : Spontaneous Ventilation
- Non opposition of patient (Groups 2 and 3) or non-opposition of patient family member (Group 1)
Exclusion Criteria:
- Known diaphragmatic paralysis
- Neurologic pathology with motor deficit
- Pregnancy or breast-feeding woman
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Mechanical Ventilation
Evolution over time of Diaphragmatic and Pectoralis muscle atrophy under Mechanical Ventilation Interventions :
|
An ultrasound of the right diaphragm will be performed on day 1, day 3, day 5 and day 10
An ultrasound of the pectoral muscle will be performed on day 1, day 3, day 5 and day 10
A neuromyopathy score will be assessed on the extubation day
An assessment of the respiratory performances will be done on the extubation day, including higher expiratory pressure, higher inspiratory pressure, and occlusion pressure
|
|
Active Comparator: Non-invasive Ventilation
Evolution over time of Diaphragmatic and Pectoralis muscle atrophy under Non-invasive Ventilation Interventions :
|
An ultrasound of the right diaphragm will be performed on day 1, day 3, day 5 and day 10
An ultrasound of the pectoral muscle will be performed on day 1, day 3, day 5 and day 10
A neuromyopathy score will be assessed on the extubation day
An assessment of the respiratory performances will be done on the extubation day, including higher expiratory pressure, higher inspiratory pressure, and occlusion pressure
|
|
Active Comparator: Spontaneous Ventilation
Evolution over time of Diaphragmatic and Pectoralis muscle atrophy under Spontaneous Ventilation Interventions :
|
An ultrasound of the right diaphragm will be performed on day 1, day 3, day 5 and day 10
An ultrasound of the pectoral muscle will be performed on day 1, day 3, day 5 and day 10
A neuromyopathy score will be assessed on the extubation day
An assessment of the respiratory performances will be done on the extubation day, including higher expiratory pressure, higher inspiratory pressure, and occlusion pressure
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from day 1 diaphragm thickness at day 3 and day 5
Time Frame: 1 day, 3 days and 5 days after introduction of Mechanical Ventilation
|
Diaphragm thickness measured by ultrasound
|
1 day, 3 days and 5 days after introduction of Mechanical Ventilation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diaphragm thickness measured by ultrasound
Time Frame: 10 days after introduction of Mechanical Ventilation
|
10 days after introduction of Mechanical Ventilation
|
|
|
Type of ventilatory support
Time Frame: 10 days after start of ventilatory support
|
Define which type of ventilatory support is used (mechanical ventilation, non-invasive ventilation, or spontaneous ventilation)
|
10 days after start of ventilatory support
|
|
Ventilatory mode
Time Frame: 10 days after start of ventilatory support
|
Ventilatory mode (controlled ventilation, pressure support ventilation)
|
10 days after start of ventilatory support
|
|
Pectoralis muscle thickness measured by ultrasound
Time Frame: 10 days after start of ventilatory support
|
To compare the importance of this atrophy to those of diaphragmatic muscle
|
10 days after start of ventilatory support
|
|
Diaphragmatic strength
Time Frame: intraoperative
|
Relation between diaphragmatic atrophy and decrease of diaphragmatic strength
|
intraoperative
|
|
Early or late extubation failure rate (extubation performed before or after 48 hours)
Time Frame: The last day of hospitalisation
|
Relation between diaphragmatic atrophy importance and premature (<48h) or late extubation failure
|
The last day of hospitalisation
|
|
MRC score (Medical Research Council)
Time Frame: intraoperative
|
Relation between diaphragmatic atrophy and decrease of diaphragmatic strength
|
intraoperative
|
|
Length of ventilation in hours
Time Frame: 10 days after start of ventilatory support
|
10 days after start of ventilatory support
|
|
|
Drug administration
Time Frame: 10 days after start of ventilatory support
|
Presence of drug administration such as curare, corticoid or sedative.
If yes : number of days with treatment
|
10 days after start of ventilatory support
|
|
Total positive end expiratory pressure
Time Frame: 10 days after start of ventilatory support
|
10 days after start of ventilatory support
|
|
|
External positive end expiratory pressure
Time Frame: 10 days after start of ventilatory support
|
10 days after start of ventilatory support
|
|
|
Respiratory rate
Time Frame: 10 days after start of ventilatory support
|
10 days after start of ventilatory support
|
|
|
Highest inspiratory pressure level
Time Frame: 10 days after start of ventilatory support
|
10 days after start of ventilatory support
|
|
|
Highest expiratory pressure level
Time Frame: 10 days after start of ventilatory support
|
10 days after start of ventilatory support
|
|
|
Volume of exhaled air
Time Frame: 10 days after start of ventilatory support
|
10 days after start of ventilatory support
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SJSL12013
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Septic Shock
-
German Center for Neurodegenerative Diseases (DZNE)University Hospital, BonnUnknownSevere Sepsis With Septic Shock | Severe Sepsis Without Septic ShockGermany
-
Artcline GmbHRecruitingSepsis | Septic Shock | Immunoparalysis in Septic ShockGermany
-
Assistance Publique - Hôpitaux de ParisCompletedSeptic Shock HyperdynamicFrance
-
Laiba QamarRecruitingSeptic Shock | Fluid Refractory Septic ShockPakistan
-
University Medicine GreifswaldUnknownSepsis Septic ShockGermany
-
Indonesia UniversityCompletedSevere Sepsis With Septic Shock | Severe Sepsis Without Septic ShockIndonesia
-
University of ZurichCompletedPatients in Septic ShockSwitzerland
-
Centre Hospitalier Universitaire DijonCompleted
-
Mansoura UniversityCompleted
-
Rennes University HospitalTerminated
Clinical Trials on Ultrasound
-
Eskisehir Osmangazi UniversityCompletedCarpal Tunnel Syndrome
-
Ahram Canadian UniversityCompletedCarpal Tunnel Syndrome | Median Neuropathy, Carpal TunnelEgypt
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Withdrawn
-
Cairo UniversityUnknown
-
Ohio State University Comprehensive Cancer CenterWithdrawn
-
Oregon Health and Science UniversityRecruiting
-
Yale UniversityCompletedPneumonia | Pulmonary Edema | DyspneaUnited States
-
Odense University HospitalEnrolling by invitationThoracic Ultrasound | Fibrosing Interstitial Lung DiseasesDenmark
-
Bursa Yüksek İhtisas Education and Research HospitalCompletedShoulder Impingement Syndrome | Shoulder PainTurkey
-
John PelleritoGeneral ElectricActive, not recruiting